We further demonstrated that the combination of the PARP inhibitor with IKZF1 degraders such as USP7 inhibitor or lenalidomide, exerts a synthetic lethal effect on MM cells in vitro and in vivo. This evidence concerns the gene USP7 and Miyoshi myopathy.